REGENXBIO Inc.
RGNX · NASDAQ
Earnings history and estimates
Reported and estimated revenue, EPS and post-earnings movement.
| Period | Date | Revenue actual | Revenue estimate | EPS actual | EPS estimate | 1D move |
|---|---|---|---|---|---|---|
| 2026 Q2 | August 6, 2026 | — | 106.91M | — | 0.12 | — |
| 2026 Q1 | May 14, 2026 | 6.39M | 25.84M | -1.72 | -1.36 | +0.18% |
| 2025 Q4 | March 5, 2026 | 30.34M | 43.96M | -1.30 | -1.01 | -4.60% |
| 2025 Q3 | November 6, 2025 | 29.73M | 59.26M | -1.20 | -1.38 | -3.79% |
| 2025 Q2 | August 7, 2025 | 21.36M | 110.02M | -1.38 | -1.13 | -4.01% |
| 2025 Q1 | May 12, 2025 | 89.01M | 105.35M | 0.12 | 0.41 | +2.63% |
| 2024 Q4 | March 13, 2025 | 21.21M | 23.70M | -1.01 | -1.27 | +2.60% |
| 2024 Q3 | November 6, 2024 | 24.20M | 23.45M | -1.17 | -1.16 | +18.66% |
| 2024 Q2 | August 1, 2024 | 22.30M | 24.33M | -1.05 | -1.29 | -2.03% |
| 2024 Q1 | May 8, 2024 | 15.62M | 23.52M | -1.38 | -1.28 | -5.94% |
| 2023 Q4 | February 27, 2024 | 22.21M | 34.00M | -1.43 | -1.27 | -0.60% |
| 2023 Q3 | November 8, 2023 | 28.91M | 36.09M | -1.41 | -1.44 | +2.44% |
| 2023 Q2 | August 2, 2023 | 19.98M | 34.50M | -1.66 | -1.26 | -7.51% |
| 2023 Q1 | May 3, 2023 | 19.14M | 30.60M | -1.53 | -1.52 | -1.58% |
| 2022 Q4 | February 28, 2023 | 31.35M | 37.45M | -1.38 | -1.48 | +8.49% |
| 2022 Q3 | November 3, 2022 | 26.51M | 30.81M | -1.75 | -1.55 | -13.16% |